 |
|
|
| |
Incidence and Determinants of Denial of DAA Therapy by Type of Insurance During the First 6 Months of the Modern HCV Treatment Era
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Vincent Lo Re, MD, MSCE
C Gowda, PN Urick, J Halladay, A Binkley, DM Carbonari, K Battista, C Peleckis, J Gilmore, JA Roy, KR Reddy,
JR Kostman
Division of Infectious Diseases
Center for Clinical Epidemiology and Biostatistics
University of Pennsylvania
|
| |
|
|
|
|
|
